Trial Profile
An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Levothyroxine sodium (Primary)
- Indications Hypothyroidism
- Focus Therapeutic Use
- Sponsors IBSA
- 25 Jun 2020 Status changed from active, no longer recruiting to completed.
- 30 Apr 2020 Planned End Date changed from 1 Apr 2020 to 1 Jun 2020.
- 30 Apr 2020 Planned primary completion date changed from 1 Apr 2020 to 1 Jun 2020.